Jen Brogan is a Journalist and Editorial Assistant at PharmaTimes Media Ltd. She covers a range of topics including the Coronavirus, data analysis, artificial intelligence, academia, and FDA regulations, often exploring the intersections of these critical areas. Jen's work has been featured in PMLiVE, Health Industry Watch, and PharmaTimes Media Ltd.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United Kingdom (National)
Not enough data
Jen Brogan's coverage primarily focuses on healthcare and pharmaceuticals, with a strong emphasis on scientific research and data-driven articles. Her work suggests receptiveness to pitches related to new medical advancements, clinical trials, significant findings in cancer research, COVID-19 treatments or studies, antibiotic resistance developments, and other breakthroughs in the healthcare sector.
Given her frequent use of press releases and citations of data along with government announcements in her articles, she may be particularly interested in receiving pitches that offer exclusive access to newsworthy data or insights from experts involved in groundbreaking medical research or clinical trials.
As Jen does not specify a geographic focus, it is likely that she covers global health-related topics without specific regional limitations. Therefore, relevant information from any part of the world could be suitable for her coverage.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Jen Brogan
Heart failure with preserved ejection fraction makes up 50% of all UK heart failure cases
By: Jen Brogan
H3 G34-mutant diffuse hemispheric gliomas are brain tumours commonly found in adolescents and young adults
By: Jen Brogan
Combined, Crohn’s disease and ulcerative colitis affect over 500,000 people in the UK
By: Jen Brogan
Children accounted for the majority of mpox cases and deaths in the DRC since June 2023
Osteoporosis, which particularly impacts older women after menopause, currently affects 3.8 million people in the UK
By: Jen Brogan
Childhood cancers, including leukaemia and lymphoma, affect 400,000 children globally every year
By: Jen Brogan
The study yielded over one million dose-responsive curves for existing cancer drugs
By: Jen Brogan
This form of cancer was responsible for 1.9 million diagnosed cases worldwide in 2020
By: Jen Brogan
The team is using AI to assist in analysing routine EEGs for early identification of brain disorders
The third most commonly diagnosed cancer globally is responsible for more than 44,000 new cases in the UK every year
(833) 317-6278 
